p.V425L | TCGA-21-5787 | LUSC | TCGA | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.6765 |
p.V425L | DO26605 | LUSC | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.6765 |
p.L789I | TCGA-AN-A046 | BRCA | TCGA | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation altering degron motif | 0.6063 |
p.L789I | DO1285 | BRCA | ICGC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation altering degron motif | 0.6063 |
p.K418N | TCGA-B5-A3FC | UCEC | TCGA | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation substituting flanking lysine | 0.25 |
p.K418N | DO41871 | UCEC | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation substituting flanking lysine | 0.25 |
p.A426V | TCGA-BR-8059 | STAD | TCGA | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.5825 |
p.A426V | DO38443 | STAD | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.5825 |
p.S429P | TCGA-D8-A1XQ | BRCA | TCGA | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.7863 |
p.S429P | DO3095 | BRCA | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.7863 |
p.S424R | TCGA-EO-A22X | UCEC | TCGA | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.75 |
p.S424R | DO43907 | UCEC | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.75 |
p.A796V | DO231906 | LINC | ICGC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.1389 |
p.A426S | DO23344 | LINC | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.6477 |
p.S429L | DO220886 | MELA | ICGC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.8778 |
p.S435R | SIDM00672 | Hepatocellular Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01265 | Plasma Cell Myeloma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00845 | Burkitt's Lymphoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01090 | Colorectal Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01117 | Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00654 | Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00690 | Head and Neck Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01112 | Osteosarcoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01099 | Neuroblastoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00529 | Breast Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00650 | Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00878 | Breast Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01247 | Burkitt's Lymphoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00703 | Non-Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00114 | Non-Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00048 | Non-Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00793 | Burkitt's Lymphoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01133 | Other Solid Cancers | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01681 | Non-Cancerous | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00956 | Esophageal Squamous Cell Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00257 | Neuroblastoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM00720 | Mesothelioma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01409 | Bladder Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S435R | SIDM01677 | Non-Small Cell Lung Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation blocking phosphorylation signal | 0.6111 |
p.S427Y | SIDM01016 | T-Lymphoblastic Leukemia | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.8231 |
p.S427Y | SIDM01263 | T-Lymphoblastic Leukemia | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.8231 |
p.S427Y | ACH-000995 | Leukemia | CCLE | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.8231 |
p.S427Y | Jurkat | haematopoietic and lymphoid tissue | COSMIC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation altering degron motif | 0.8231 |
p.S790F | SIDM00545 | Melanoma | GDSC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.S790F | SIDM00527 | Colorectal Carcinoma | GDSC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.S790F | ACH-000935 | Colon/Colorectal Cancer | CCLE | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.S790F | ACH-000987 | Skin Cancer | CCLE | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.S790F | Mewo | skin | COSMIC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.S790F | MDST8 | large intestine | COSMIC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.A794S | SIDM00198 | Ewing's Sarcoma | GDSC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.1944 |
p.A794S | ACH-002114 | Bone Cancer | CCLE | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.1944 |
p.A794S | EW-16 | bone | COSMIC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.1944 |
p.P783S | SIDM01133 | Other Solid Cancers | GDSC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.2778 |
p.P783S | ACH-002177 | Lung Cancer | CCLE | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.2778 |
p.P783S | NCI-H835 | lung | COSMIC | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.2778 |
p.R430W | SIDM01619 | Endometrial Carcinoma | GDSC | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation rewiring degron network | 0.3056 |
p.R430W | ACH-000984 | Endometrial/Uterine Cancer | CCLE | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation rewiring degron network | 0.3056 |
p.S790P | ACH-001607 | Gallbladder Cancer | CCLE | KKENL | DEG_APCC_KENBOX_2 | 785:789 | Mutation rewiring degron network | 0.3056 |
p.K418R | ACH-001786 | Colon/Colorectal Cancer | CCLE | VASSS | DEG_SPOP_SBC_1 | 425:429 | Mutation substituting flanking lysine | 0.25 |